Equity Incentive Plans (Tables)
|
3 Months Ended |
12 Months Ended |
Dec. 31, 2023 |
Sep. 30, 2023 |
| Equity Incentive Plans [Abstract] |
|
|
| Schedule of Summary of Activity in the Company's RSUs |
A summary of activity in the Company’s RSUs for the three months ended December 31, 2023 is as follows:
|
|
|
Number of
units
|
|
Weighted-Average
Grant Date Fair
Value per Unit
|
|
Outstanding at September 30, 2023
|
|
209,494 |
|
|
$
|
6.84 |
|
Performance-based RSUs
|
|
4,000,000 |
|
|
$
|
10.58 |
|
Vested
|
|
(104,748 |
)
|
|
$
|
6.84 |
|
Cancelled
|
|
—
|
|
|
$
|
—
|
|
Outstanding at December 31, 2023
|
|
4,104,746 |
|
|
$
|
10.48 |
|
A summary of activity in the Company’s RSUs for the year ended September 30, 2023 is as follows:
|
|
|
Number of
units
|
|
Weighted-Average
Grant Date Fair
Value per Unit
|
|
Outstanding at September 30, 2022
|
|
10,984,241 |
|
|
$
|
6.84 |
|
Cancelled
|
|
(10,774,747 |
)
|
|
$
|
6.84 |
|
Outstanding at September 30, 2023
|
|
209,494 |
|
|
$
|
6.84 |
|
| Schedule of Stock Option Activity |
Stock option activity for the three months ended December 31, 2023 is as follows:
|
|
|
Number of
Options
|
|
Weighted-Average
Exercise Price
per Share
|
|
Weighted-Average
Remaining
Contractual
Term (years)
|
|
Outstanding at September 30, 2023
|
|
5,905,684 |
|
|
$
|
4.28 |
|
|
|
Granted
|
|
32,200 |
|
|
$
|
6.84 |
|
|
|
Exercised
|
|
(390,440 |
)
|
|
$
|
5.80 |
|
|
|
Expired
|
|
(138,543 |
)
|
|
$
|
5.99 |
|
|
|
Outstanding at December 31, 2023
|
|
5,408,901 |
|
|
$
|
4.14 |
|
7.4 |
|
Exercisable at December 31, 2023
|
|
4,055,326 |
|
|
$
|
3.29 |
|
7.0 |
|
Stock option activity for the year ended September 30, 2023 is as follows:
|
|
|
Number of
Options
|
|
Weighted-Average
Exercise
Price per Share
|
|
Weighted-Average
Remaining
Contractual
Term (years)
|
|
Outstanding at September 30, 2022
|
|
5,754,052 |
|
|
$
|
4.16 |
|
|
|
Granted
|
|
780,506 |
|
|
$
|
6.84 |
|
|
|
Forfeited
|
|
(628,874 |
)
|
|
$
|
6.37 |
|
|
|
Outstanding at September 30, 2023
|
|
5,905,684 |
|
|
$
|
4.28 |
|
7.5 |
|
Exercisable at September 30, 2023
|
|
4,226,353 |
|
|
$
|
3.39 |
|
7.1 |
|
| Schedule of Weighted-Average Grant Date Fair Value of Options Granted |
The fair value of stock options granted was estimated with the following assumptions:
|
|
|
Three months ended December 31,
|
| |
|
2023
|
|
2022
|
| |
|
Range
|
|
Range
|
| |
|
Low
|
|
High
|
|
Low
|
|
High
|
|
Expected volatility
|
|
54.8 |
%
|
|
55.6 |
%
|
|
52.4 |
%
|
|
53.6 |
%
|
|
Expected dividend yield
|
|
0 |
%
|
|
0 |
%
|
|
0 |
%
|
|
0 |
%
|
|
Risk-free interest rate
|
|
3.9 |
%
|
|
4.4 |
%
|
|
3.6 |
%
|
|
4.2 |
%
|
|
Expected term (years)
|
|
4.5 |
|
|
5.3 |
|
|
5.0 |
|
|
5.8 |
|
|
The fair value of stock options granted was estimated with the following assumptions:
|
|
|
Years ended September 30,
|
| |
|
2023
|
|
2022
|
| |
|
Range
|
|
Range
|
| |
|
Low
|
|
High
|
|
Low
|
|
High
|
|
Expected volatility
|
|
52.4 |
%
|
|
54.4 |
%
|
|
50.5 |
%
|
|
50.9 |
%
|
|
Expected dividend yield
|
|
0 |
%
|
|
0 |
%
|
|
0 |
%
|
|
0 |
%
|
|
Risk-free interest rate
|
|
3.6 |
%
|
|
4.2 |
%
|
|
1.0 |
%
|
|
3.6 |
%
|
|
Expected term (years)
|
|
4.6 |
|
|
5.8 |
|
|
4.1 |
|
|
6.1 |
|
|
| Schedule of Statements of Operations and Comprehensive Loss |
The condensed consolidated statements of operations and comprehensive income (loss) include stock-based compensation expense as follows:
|
|
|
Three months ended
December 31,
|
| |
|
2023
|
|
2022
|
|
Cost of revenue
|
|
$
|
—
|
|
$
|
11 |
|
Research and development
|
|
|
501 |
|
|
542 |
|
Selling, general and administrative
|
|
|
12,204 |
|
|
3,303 |
|
Total stock-based compensation expense
|
|
$
|
12,705 |
|
$
|
3,856 |
|
The statements of operations and comprehensive loss include stock-based compensation expense as follows:
|
|
|
Year ended September 30,
|
| |
|
2023
|
|
2022
|
|
Cost of revenues
|
|
$
|
31 |
|
$
|
14 |
|
Research and development
|
|
|
1,842 |
|
|
759 |
|
Selling, general and administrative
|
|
|
13,603 |
|
|
2,517 |
|
Total stock-based compensation expense
|
|
$
|
15,476 |
|
$
|
3,290 |
|